Concerns Around Budget Impact Thresholds: Not All Drugs Are the Same.

Background: The use of budget thresholds is a recent development in the United States (e.g., the Institute for Clinical and Economic Review drug assessments).

Size and usage patterns of private TB drug markets in the high burden countries.

Background: Tuberculosis (TB) control is considered primarily a public health concern, and private sector TB treatment has attracted less attention. Thus, the size and characteristics of private sector TB drug sales remain largely unknown.

Methodology/principal Findings: We used IMS Health data to analyze private TB drug consumption in 10 high burden countries (HBCs), after first mapping how well IMS data coverage overlapped with private markets.